Industry Summits
Health care sector gears up for U.S. reform
NEW YORK (Reuters) - Drug makers, insurers and other health care companies are preparing for possibly dramatic changes to the U.S. health care system as Democrats increase their power in Washington next year. Full Article
More money and strong leader wanted at FDA
NEW YORK (Reuters) - Drug makers are calling for steady leadership, political independence and a boost in funding to improve the climate at the U.S. Food and Drug Administration under President-elect Barack Obama. Full Article
Pharma overhaul under way ahead of challenges
NEW YORK (Reuters) - Leaders of the world's largest drug makers are all under the hood working to overhaul a rusty business model, even as they differ over the right new parts. Full Article
Sign up here to be alerted via email about top news broken from these exclusive interviews, as well as the list of guests for upcoming Reuters Summits.
Daiichi confident of Effient approval
NEW YORK (Reuters) - Daiichi-Sankyo's top U.S. executive expressed confidence that the blood clot preventer it is developing with Eli Lilly & Co will soon win U.S. approval, and said the sales force for the medicine was champing at the bit to get started. Full Article | Video
Walgreen makes Times Square return as it revamps
CHICAGO (Reuters) - Walgreen Co has more than 6,500 drugstores across the United States, but only one of them can help the chain reach billions of people, even if they never step inside. Full Article | Video
Pharmaceuticals can't escape recessionary chill
NEW YORK (Reuters) - It may still carry a defensive tag, but the pharmaceuticals industry won't escaped unscathed as economies around the world are pitched into recession. Full Article
Is biotech really such a bargain?
NEW YORK (Reuters) - Cash-strapped biotechs may be hoping Big Pharma rides to the rescue, but they shouldn't count on it. Full Article
Pfizer pegs growth to overseas, older drugs
NEW YORK (Reuters) - Pfizer Inc's top executive is counting on higher sales in emerging markets and revenue from older medicines to generate enough revenue in the next three years to help offset an expected plunge in sales of its top selling Lipitor cholesterol drug. Full Article
Pfizer, others still chasing obesity drugs
NEW YORK (Reuters) - After pulling the plug on an experimental obesity drug from a troubled class of medicines, Pfizer Inc's Chief Executive Jeff Kindler said the world's largest drug maker would continue to pursue treatments for the emerging health crisis. Full Article
Pfizer CEO: Independence needed at FDA
NEW YORK (Reuters) - The U.S. Food and Drug Administration was hurt by turnover at the top during the George W. Bush administration and needs a strong, independent leader, Pfizer Inc Chief Executive Jeff Kindler said on Thursday. Full Article
More Health News
Speakers
What are Summits?
Reuters Summits are your direct link to top business leaders, investors and regulators. Our journalists interview heavyweights in a particular industry, spin out hard-hitting breaking news and sharp analysis that can often move markets. If you want to understand what the insiders are thinking, look for Reuters Summits. Launch Full Video
| Japan Investment | Jul 7 - 8 | Tokyo |
| Paper and Packaging | Aug 24 - 25 | Helsinki |
| China Investment | Aug 31 - Sep 2 | Beijing, Shanghai, Hong Kong |
| Global Climate and Alternative Energy | Sep 8 - 10 | Global, virtual |
| Russia Investment | Sep 14 - 16 | Moscow |
| Restructuring | Sep 28 - 29 | New York |
| Global Wealth Management | Oct 5 - 7 | Boston, Geneva, Tokyo, Singapore |
| Central European Investment | Oct 12 - 14 | Vienna |
| Washington | Oct 19 - 21 | Washington, DC |
| Middle East Investment | Oct 26 - 28 | Dubai, Kuwait |
| Autos | Nov 2 - 4 | Detroit, Paris |
| Health | Nov 9 - 12 | New York |
| Global Finance | Nov 16 - 19 | New York, London, Hong Kong |
| India Investment | Nov 23 - 25 | Mumbai, Bangalore |
| Global Media | Nov 30 - Dec 3 | New York, London, Asia |
| Investment Outlook | Dec 8 - 10 | New York, London |
| Aerospace and Defense | Dec 14 - 16 | Washington, DC |
